CR7648A - Microcapsulas para la liberacion retardada y controlada del perindropil - Google Patents

Microcapsulas para la liberacion retardada y controlada del perindropil

Info

Publication number
CR7648A
CR7648A CR7648A CR7648A CR7648A CR 7648 A CR7648 A CR 7648A CR 7648 A CR7648 A CR 7648A CR 7648 A CR7648 A CR 7648A CR 7648 A CR7648 A CR 7648A
Authority
CR
Costa Rica
Prior art keywords
delayed
perindropil
microcapsules
controlled liberation
liberation
Prior art date
Application number
CR7648A
Other languages
English (en)
Inventor
Patrick Wutrich
De Abroches Bruno Huet
Valerie Legrand
Catherine Castan
Remi Meyrueix
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of CR7648A publication Critical patent/CR7648A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)

Abstract

Se refiere a capsulas que permiten la liberacion retardada y controlada del perindropil, o de una de sus sales farmaceuticamente aceptables destinadas a una administracion por via oral.
CR7648A 2002-06-24 2005-01-11 Microcapsulas para la liberacion retardada y controlada del perindropil CR7648A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0207778A FR2841140B1 (fr) 2002-06-24 2002-06-24 Microcapsules pour la liberation retardee et controlee du perindopril

Publications (1)

Publication Number Publication Date
CR7648A true CR7648A (es) 2005-07-18

Family

ID=29719985

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7648A CR7648A (es) 2002-06-24 2005-01-11 Microcapsulas para la liberacion retardada y controlada del perindropil

Country Status (37)

Country Link
US (1) US20060165808A1 (es)
EP (1) EP1515704B1 (es)
JP (1) JP4723243B2 (es)
KR (1) KR100722082B1 (es)
CN (1) CN100345541C (es)
AP (1) AP2029A (es)
AR (1) AR040461A1 (es)
AT (1) ATE429214T1 (es)
AU (1) AU2003260620B2 (es)
BR (1) BR0312026A (es)
CA (1) CA2491172C (es)
CR (1) CR7648A (es)
CY (1) CY1109154T1 (es)
DE (1) DE60327318D1 (es)
DK (1) DK1515704T3 (es)
EA (1) EA007571B1 (es)
EC (1) ECSP055570A (es)
ES (1) ES2326218T3 (es)
FR (1) FR2841140B1 (es)
GE (1) GEP20074212B (es)
HR (1) HRP20050055B1 (es)
IL (1) IL165896A0 (es)
IS (1) IS2679B (es)
MA (1) MA27262A1 (es)
ME (1) ME00452B (es)
MX (1) MXPA05000086A (es)
NO (1) NO20050163L (es)
NZ (1) NZ537408A (es)
OA (1) OA12875A (es)
PL (1) PL374377A1 (es)
PT (1) PT1515704E (es)
RS (1) RS50914B (es)
SI (1) SI1515704T1 (es)
TN (1) TNSN04259A1 (es)
UA (1) UA81121C2 (es)
WO (1) WO2004000286A1 (es)
ZA (1) ZA200410333B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
BRPI0615607A2 (pt) * 2005-08-30 2011-05-24 Lek Pharmaceuticals composição farmacêutica compreendendo perindopril ou seus sais
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
FR2897865B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FI125776B2 (fi) 2008-06-27 2023-07-28 Metsaeliitto Osuuskunta Menetelmä puulevyn käsittelemiseksi
CN106983731A (zh) * 2017-04-20 2017-07-28 上药东英（江苏）药业有限公司 一种培哚普利控释片及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2247186A1 (de) * 1972-09-26 1974-03-28 Bayer Ag Antimykotisches mittel
JPS55129219A (en) * 1979-03-29 1980-10-06 Asahi Chem Ind Co Ltd Slow-releasing preparation
HU218673B (hu) * 1993-10-07 2000-10-28 Euroceltique S.A. Opioid analgetikumot tartalmazó elnyújtott hatóanyag-felszabadítású orális gyógyszerkészítmény és eljárás előállítására
DE19724696A1 (de) * 1997-06-12 1998-12-24 Hexal Ag Pharmazeutische Zubereitung mit drei Pelletarten
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
JPH11171769A (ja) * 1997-12-05 1999-06-29 Nichiko Pharmaceutical Co Ltd ３−イソブチリル−２−イソプロピルピラゾロ〔１，５−ａ〕ピリジンの徐放性製剤及びその製法
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
AU2001261434A1 (en) * 2000-05-11 2001-11-26 Pharmacia Corporation Aldosterone antagonist composition for release during aldosterone acrophase
CN100553625C (zh) * 2002-04-09 2009-10-28 弗拉梅技术公司 活性成分微囊的口服混悬液
CN1189150C (zh) * 2002-11-07 2005-02-16 张凤英 祛斑美白面膜
CN100389300C (zh) * 2004-01-17 2008-05-21 湖北清江水布垭工程建设公司 大坝面板挠度或坝体内部变形监测方法及装置

Also Published As

Publication number Publication date
SI1515704T1 (sl) 2009-08-31
ME00452B (me) 2011-10-10
RS112904A (sr) 2007-02-05
CN100345541C (zh) 2007-10-31
MXPA05000086A (es) 2005-04-08
OA12875A (en) 2006-09-15
HRP20050055A2 (en) 2005-02-28
AU2003260620A1 (en) 2004-01-06
JP2005533079A (ja) 2005-11-04
KR20050023337A (ko) 2005-03-09
ES2326218T3 (es) 2009-10-05
EP1515704B1 (fr) 2009-04-22
ECSP055570A (es) 2006-04-19
MA27262A1 (fr) 2005-03-01
CA2491172A1 (fr) 2003-12-31
JP4723243B2 (ja) 2011-07-13
FR2841140B1 (fr) 2004-10-01
IL165896A0 (en) 2006-01-15
CN1665491A (zh) 2005-09-07
IS2679B (is) 2010-09-15
AR040461A1 (es) 2005-04-06
DK1515704T3 (da) 2009-07-20
AP2029A (en) 2009-08-24
UA81121C2 (en) 2007-12-10
AU2003260620B2 (en) 2008-07-31
EA007571B1 (ru) 2006-12-29
EP1515704A1 (fr) 2005-03-23
HRP20050055B1 (hr) 2013-11-08
ATE429214T1 (de) 2009-05-15
EA200500030A1 (ru) 2005-06-30
GEP20074212B (en) 2007-10-10
US20060165808A1 (en) 2006-07-27
NO20050163L (no) 2005-01-12
DE60327318D1 (de) 2009-06-04
ZA200410333B (en) 2006-07-26
PL374377A1 (en) 2005-10-17
NZ537408A (en) 2006-07-28
TNSN04259A1 (fr) 2007-03-12
AP2004003193A0 (en) 2004-12-31
FR2841140A1 (fr) 2003-12-26
RS50914B (sr) 2010-08-31
BR0312026A (pt) 2005-03-22
IS7634A (is) 2005-01-07
CA2491172C (fr) 2011-02-15
CY1109154T1 (el) 2014-07-02
WO2004000286A1 (fr) 2003-12-31
PT1515704E (pt) 2009-05-20
KR100722082B1 (ko) 2007-05-25

Similar Documents

Publication Publication Date Title
ES2176106B1 (es) Comprimido matricial de liberacion prolongada de trimetazidina tras su administracion por via oral.
AR045972A1 (es) Formulaciones de tramadol de liberacion sostenida con eficacia de 24 horas
HN2003000183A (es) Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
AR065809A1 (es) Formulaciones farmaceuticas que contienen un inhibidor sglt2
ECSP066365A (es) Anilino purinas sustituidas en la posición 6 útiles como inhibidores de rtk
ECSP055568A (es) Composición de comprimido de liberación sostenida de pramipexol
HN2003000407A (es) Nuevos derivados de fluoroglicosisdos aromaticos, medicamentos que contienen estos compuestos y sus usos.
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
ES2119034T3 (es) Preparaciones farmaceuticas de sales de tramadol de liberacion retardada.
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
ECSP056229A (es) Una composición farmacéutica que comprende formas polimórficas de 3-(4-amino-1-oxo-1.3 dyhidro-isoindol-2-il)-piperidina-2,6-diona para el tratamiento y manejo de cánceres
HN2003000185A (es) Difenilazetidinonas sustituidas en grupo acido, procedimiemto para su preparacion, medicamentos que comprenden estso compuestos y su uso.
CO6612204A2 (es) Nuevas composiciones de 1-(2(2.4 dimetil-fenilsulfanil)- fenil) piperazina
CO6270217A2 (es) Formulaciones galenicas de alisquireno y valsartan
CL2003002653A1 (es) Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar
ATE347358T1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
FI20000780L (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
CR7648A (es) Microcapsulas para la liberacion retardada y controlada del perindropil
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
PA8555201A1 (es) Formas pseudopolimorficas de carvedilol
AR042037A1 (es) Profarmaco de celecoxib
CO5700723A2 (es) Uso de un derivado de amina ciclica especifico o de sus sales farmaceuticamente aceptables para tratar y prevenir la insuficiencia cardiaca
NO20043633L (no) Oral doseringsform for kontrollert medikamentfrigivning